Medical Devices Latin America

Latin America Breath Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Latin America Breath Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Application, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Latin America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $46.6 Mn Placeholder estimate
Estimate 2025 $52.8 Mn 4.7% of the global market
Projected 2034 $162.3 Mn 207.7% Adds $109.6 Mn over 9 forecast years
CAGR 2025–2034 13.3% Faster than 82% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Latin America is 4.67% of the global market.
  • Among regions, the largest is North America at $624.6 Mn.
  • Fastest growing: APAC at 13.5% a year.
  • Latin America ranks 4th of 6 by size among regions.

Market size projection

Latin America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$109.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Breath Diagnostics Market market size by year, Latin America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $46.6 Mn — —
2025 (base) $52.8 Mn +$6.2 Mn —
2026 (forecast) $59.8 Mn +$7.0 Mn +13.3%
2027 (forecast) $67.7 Mn +$8.0 Mn +28.4%
2028 (forecast) $76.7 Mn +$9.0 Mn +45.4%
2029 (forecast) $86.9 Mn +$10.2 Mn +64.8%
2030 (forecast) $98.5 Mn +$11.6 Mn +86.7%
2031 (forecast) $111.6 Mn +$13.1 Mn +111.5%
2032 (forecast) $126.4 Mn +$14.8 Mn +139.7%
2033 (forecast) $143.3 Mn +$16.8 Mn +171.5%
2034 (forecast) $162.3 Mn +$19.1 Mn +207.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Latin America Breath Diagnostics Market Analysis at a glance
Market size, 2025$52.8 Mn placeholder estimate
Forecast, 2034$162.3 Mn placeholder estimate
Growth (CAGR), 2025–203413.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, technology and end user (see all)
Key playersOwlstone Medical, Circassia (NIOX), Exalenz Bioscience, Kibion, Breathtec Biomedical (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Latin America Breath Diagnostics Market Analysis Executive Summary

Breath diagnostics analyse molecules in exhaled breath to detect diseases such as H. pylori infection, asthma and some cancers.

Key segments of the breath Diagnostics market include application (H. pylori Testing, Asthma (FeNO) and Gut Disorders) and technology (Urea Breath Tests, FeNO Analyzers and Mass Spectrometry).

Bar chart: Latin America Breath Diagnostics market size, 2024–2034, placeholder estimates. $46.6 Mn in 2024, $52.8 Mn in 2025 and $162.3 Mn in 2034, 13.3% CAGR.
Latin America Breath Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Latin America Breath Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the breath Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the breath Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the breath Diagnostics market.

Competitive Landscape for Breath Diagnostics Market in Latin America

The breath Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Breath Diagnostics Market in Latin America

Breath Diagnostics in Latin America: rules and payment

In some of the countries we cover here, medical devices are regulated by ANVISA (Brazil)⁠[1], ARCSA (Ecuador)⁠[2] and COFEPRIS (Mexico)⁠[3]. How care is paid for in some of these countries: the SUS (Brazil)⁠[4]; public care and IESS (Ecuador)⁠[5]; and IMSS, ISSSTE and IMSS-Bienestar (Mexico)⁠[6].

[1] ANVISA. Checked 14 Nov 2026.

[2] ARCSA. Checked 14 Nov 2026.

[3] COFEPRIS. Checked 14 Nov 2026.

[4] CONITEC. Checked 14 Nov 2026.

[5] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.

[6] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how breath Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Latin America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Breath Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Breath Diagnostics in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Breath Diagnostics market in Latin America?
Placeholder estimate: about $52.8 Mn in 2025, rising to about $162.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Breath Diagnostics market in Latin America growing?
Placeholder estimate: about 13.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Breath Diagnostics market report cover?
The report splits the market by application (H. pylori Testing, Asthma (FeNO), Gut Disorders, Cancer Detection), technology (Urea Breath Tests, FeNO Analyzers, Mass Spectrometry, Electronic Nose) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Breath Diagnostics market?
Key players include Owlstone Medical, Circassia (NIOX), Exalenz Bioscience, Kibion and Breathtec Biomedical.
What is driving the Breath Diagnostics market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the breath Diagnostics market.
How much research is published on Breath Diagnostics?
PubMed lists 11,191 papers on Breath Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Latin America

See all

Related on diagnostics and lab testing and respiratory

See the topic